
- /
- Supported exchanges
- / US
- / CRL.NYSE
Charles River Laboratories (CRL NYSE) stock market data APIs
Charles River Laboratories Financial Data Overview
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Charles River Laboratories data using free add-ons & libraries
Get Charles River Laboratories Fundamental Data
Charles River Laboratories Fundamental data includes:
- Net Revenue: 4 023 M
- EBITDA: 889 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 2.0748
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Charles River Laboratories News

Guru Fundamental Report for CRL
Below is Validea's guru fundamental report for CHARLES RIVER LBRTRS NTRNTL INC (CRL). Of the 22 guru strategies we follow, CRL rates highest using our Shareholder Yield Investor model based on the pu...


Is Charles River Laboratories Stock Underperforming the S&P 500?
Charles River Laboratories International Inc_ logo- by IgorGolovniov via Shutterstock Valued at a market cap of $7.3 billion, Charles River Laboratories International, Inc. (CRL) provides drug discov...

Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season. Companies specializing in drug ...

3 Reasons to Sell CRL and 1 Stock to Buy Instead
Charles River Laboratories’s stock price has taken a beating over the past six months, shedding 20.8% of its value and falling to $145.05 per share. This may have investors wondering how to approach...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.